Longitudinal study of short‐term corticosteroid use by working‐age adults with diabetes mellitus: Risks and mitigating factors: 处于工作年龄的成年糖尿病患者短期使用糖皮质激素治疗的纵向研究:风险与缓解因素. Issue 7 (5th January 2018)

• Record Type: Journal Article
• Authors: Rogers, Mary A.M.; Lin, Paul; Nallamothu, Brahmajee K.; Kim, Catherine; Waljee, Akbar K.
• Is Part Of: Journal of diabetes. Volume 10:Issue 7(2018)
• Page Start: 546
• Page End: 555
• Publication Date: 2018-01-05
• Subjects: corticosteroids -- diabetes mellitus -- drug‐related side effects and adverse reactions -- statins -- vitamin D; 糖皮质激素 -- 糖尿病 -- 药物相关副作用与不良反应 -- 他汀类药物 -- 维生素D; Diabetes -- Periodicals; 618.3646005
• DOI: 10.1111/1753-0407.12631
• Languages: English
• ISSNs: 1753-0393

Abstract

Abstract: Background: This study assessed the frequency of short‐term oral corticosteroid use in adults with diabetes, examined the incidence of fractures, venous thromboembolism (VTE), and hospitalization for sepsis after corticosteroid use, and evaluated whether preventative medications mitigated adverse events. Methods: A longitudinal study (2012–14) was conducted of 1 548 945 adults (aged 18–64 years) who received healthcare coverage through a large national health insurer. Incidence rate ratios (IRR) were calculated using conditional Poisson regression. Results: Short‐term oral corticosteroids were used by 23.9%, 20.8%, and 20.9% of adults with type 2 diabetes, type 1 diabetes, and no diabetes, respectively, during the 3‐year period ( P < 0.001). Baseline risks of fracture, VTE, and sepsis were greater for individuals with than without diabetes ( P < 0.001). The combined effect of having diabetes and using corticosteroids was greater than the sum of the individual effects (synergy indices of 1.17, 1.23, 1.30 for fracture, VTE, and sepsis, respectively). The IRR for VTE in the 5–30 days after corticosteroid use was 3.62 (95% confidence interval [CI] 2.41–5.45). Fractures increased in the 5–30 days after corticosteroid use (IRR 2.06; 95% CI 1.52, 2.80), but concomitant use of ergocalciferol mitigated this risk (IRR 1.13; 95% CI 0.12, 11.07). The risk of hospitalization for sepsis was elevated with corticosteroid use (IRR 3.79; 95% CI 2.05, 7.01), but was mitigated by the concomitant use of statins. Conclusions: Short‐term oral corticosteroid use is common in adults with diabetes and is associated with an elevated, but low, risk of adverse events. The findings suggest that preventative medications may mitigate risk. Abstract : Highlights Adults with diabetes mellitus have a greater risk of fracture, venous thromboembolism, and sepsis than those without diabetes; the use of corticosteroids, even for short durations, increases this risk. Vitamin D mitigated the risk of fracture in patients with diabetes who used corticosteroids, and statins decreased the likelihood of hospitalization for sepsis in corticosteroid users with diabetes. Corticosteroids should be used with caution in patients with diabetes and mitigating factors should be considered.